FDA fast-tracks psychedelic drug research following Trump executive orderIt's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.{}

It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.https://www.cnbc.com/2026/04/24/fda-psychedelic-drug-research-trump.html